AU2003227847A1 - Composition in an aqueous gel state, method for the production and use thereof in the production of a medicament, in particular an antiherpetic medicament - Google Patents

Composition in an aqueous gel state, method for the production and use thereof in the production of a medicament, in particular an antiherpetic medicament

Info

Publication number
AU2003227847A1
AU2003227847A1 AU2003227847A AU2003227847A AU2003227847A1 AU 2003227847 A1 AU2003227847 A1 AU 2003227847A1 AU 2003227847 A AU2003227847 A AU 2003227847A AU 2003227847 A AU2003227847 A AU 2003227847A AU 2003227847 A1 AU2003227847 A1 AU 2003227847A1
Authority
AU
Australia
Prior art keywords
medicament
production
antiherpetic
composition
aqueous gel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003227847A
Inventor
Andre Bianchi
Didier Paluszezak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PALBIAN SNC
Original Assignee
PALBIAN SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PALBIAN SNC filed Critical PALBIAN SNC
Publication of AU2003227847A1 publication Critical patent/AU2003227847A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2003227847A 2002-03-18 2003-03-18 Composition in an aqueous gel state, method for the production and use thereof in the production of a medicament, in particular an antiherpetic medicament Abandoned AU2003227847A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR02/03318 2002-03-18
FR0203318A FR2837102B1 (en) 2002-03-18 2002-03-18 AQUEOUS GEL COMPOSITION, MANUFACTURING METHOD AND USE FOR THE MANUFACTURE OF A MEDICAMENT, ESPECIALLY ANTIHERPETIC
PCT/FR2003/000862 WO2003077922A1 (en) 2002-03-18 2003-03-18 Composition in an aqueous gel state, method for the production and use thereof in the production of a medicament, in particular an antiherpetic medicament

Publications (1)

Publication Number Publication Date
AU2003227847A1 true AU2003227847A1 (en) 2003-09-29

Family

ID=27772205

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003227847A Abandoned AU2003227847A1 (en) 2002-03-18 2003-03-18 Composition in an aqueous gel state, method for the production and use thereof in the production of a medicament, in particular an antiherpetic medicament

Country Status (3)

Country Link
AU (1) AU2003227847A1 (en)
FR (1) FR2837102B1 (en)
WO (1) WO2003077922A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8697712B2 (en) * 2004-04-05 2014-04-15 Laboratorios Liomont, S.A. De C.V. Presentation of an antiviral pharmaceutical composition
US20110092597A1 (en) * 2009-10-21 2011-04-21 Fangchen Lee Method for treating herpes virus infection

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
EP0551626A1 (en) * 1991-12-19 1993-07-21 LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation
IL104283A (en) * 1992-12-30 1996-12-05 Agis Ind 1983 Ltd Non-emulsion antiviral topical pharmaceutical composition comprising acyclovir an aqueous gel agent and an alkali oleate
IL108366A (en) * 1993-03-11 1999-11-30 Taro Vit Ind Ltd Pharmaceutical compositions in semisolid form and a squeezable container for administration thereof
GB9408545D0 (en) * 1994-04-29 1994-06-22 Zyma Sa Compositions
DE4425322A1 (en) * 1994-07-18 1996-01-25 Merck Patent Gmbh Virostatics in a hydrophobic base for topical use
AU4472396A (en) * 1994-12-30 1996-07-24 American Home Products Corporation Clear non-alcoholic hydrocortisone solutions
TW438585B (en) * 1995-02-06 2001-06-07 Astra Ab Pharmaceutical compositions for topical administration for prophylaxis and/or treatment of herpesvirus infections
IT1275955B1 (en) * 1995-03-22 1997-10-24 Dompe Spa PHARMACEUTICAL FORMULATIONS IN THE FORM OF THISSOTROPIC GEL
WO1997034607A1 (en) * 1996-03-20 1997-09-25 Glaxo Group Limited Topical formulations of aciclovir
US6416779B1 (en) * 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
GB9718791D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
WO2003077922A1 (en) 2003-09-25
FR2837102B1 (en) 2004-10-08
FR2837102A1 (en) 2003-09-19

Similar Documents

Publication Publication Date Title
AU2003282094A1 (en) Novel dihydroxy-methylphenyl derivatives, method for the production and use thereof as medicaments
AU2003289872A1 (en) Novel xanthin derivatives, production and use thereof as medicaments
AU2009248461A1 (en) Ophthalmologic irrigation solutions and method
AU2002234640A1 (en) Xanthine derivative, production and use thereof as a medicament
AU2003293649A1 (en) Novel xanthine derivatives, the production and the use thereof in the form of drugs
AU2003266194A1 (en) Nanocomposite, method for production and use thereof
AU2003257465A1 (en) Substituted diaryl heterocycles, method for the production and use thereof as medicaments
HRP20040930A2 (en) Acyl-4-carboxyphenylurea derivatives, method for production and use thereof
AU2003289065A1 (en) Oxide nanostructure, method for producing same, and use thereof
AU2003206760A1 (en) Anticholinergic agents, method for producing the same and use thereof as medicaments
AU2003255645A1 (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
HK1075650A1 (en) Acyl-3-carboxyphenylurea derivatives, method for production and use thereof
AU2003269018A1 (en) Acylaminothiazole derivatives, preparation and therapeutic use thereof
AU3301700A (en) (n)-sulfonyl-dipeptide derivatives, production and use thereof in therapy
EP1578730A3 (en) Piezoceramic composition, piezoceramic body comprising said composition and a method for producing said composition and said body
TWI318211B (en) Novel derivatives of 4a, 5, 9, 10, 11, 12-hexahydrobenzofuro [3a, 2, 2] [2] -benzazepine, method for the production thereof and use thereof in the production of medicaments
AU2002233407A1 (en) 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
AU2003254556A1 (en) Indoline derivatives substituted in position 6, production and use thereof as medicaments
AU2003232244A1 (en) Nanofiller, production, and use
EP1147748A3 (en) Endocanal pin for dental use and relative production method
AU2003227847A1 (en) Composition in an aqueous gel state, method for the production and use thereof in the production of a medicament, in particular an antiherpetic medicament
AU2001254812A1 (en) 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations
AU2003900495A0 (en) Aroylhydrazone derivatives and therapeutic uses thereof
AU2003246840A1 (en) Anti-hiv composition, production method thereof and medicament
AU2003229863A1 (en) Porphyrin derivatives, method for the production thereof, pharmaceutical compositions and use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase